rdf:type |
|
lifeskim:mentions |
umls-concept:C0021641,
umls-concept:C0030705,
umls-concept:C0033975,
umls-concept:C0036341,
umls-concept:C0205250,
umls-concept:C0299583,
umls-concept:C0439849,
umls-concept:C0441889,
umls-concept:C0445223,
umls-concept:C0596192,
umls-concept:C1552599,
umls-concept:C1704787
|
pubmed:issue |
10
|
pubmed:dateCreated |
2000-11-14
|
pubmed:abstractText |
The aim of this study was to investigate the influence of the antipsychotic agent olanzapine on glucose-insulin homeostasis to explain possible mechanisms behind olanzapine-associated weight gain.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0160-6689
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
742-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11078035-Adult,
pubmed-meshheading:11078035-Antipsychotic Agents,
pubmed-meshheading:11078035-Benzodiazepines,
pubmed-meshheading:11078035-Blood Glucose,
pubmed-meshheading:11078035-Body Weight,
pubmed-meshheading:11078035-Chromatography, High Pressure Liquid,
pubmed-meshheading:11078035-Female,
pubmed-meshheading:11078035-Humans,
pubmed-meshheading:11078035-Insulin,
pubmed-meshheading:11078035-Leptin,
pubmed-meshheading:11078035-Lipids,
pubmed-meshheading:11078035-Male,
pubmed-meshheading:11078035-Middle Aged,
pubmed-meshheading:11078035-Pirenzepine,
pubmed-meshheading:11078035-Psychotic Disorders,
pubmed-meshheading:11078035-Schizophrenia,
pubmed-meshheading:11078035-Triglycerides
|
pubmed:year |
2000
|
pubmed:articleTitle |
Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
|
pubmed:affiliation |
Department of Psychiatry, St Görans Hospital, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|